Interleukin-6’s role in diabetic retinopathy suggests potential treatment.

The Atlanta Business Chronicle (1/22, Karakaria) reported that Medical College of Georgia researchers reported online in Investigative Ophthalmology & Visual Science that “Interleukin-6, known to contribute to the debilitating joint inflammation of rheumatoid arthritis, also helps ignite inflammation of the retina, a first step in” diabetic retinopathy. In response, researchers are “looking at whether an interleukin-6 antibody, which is showing success in treating rheumatoid arthritis, can halt inflammation in mice with diabetic retinopathy.”

For more informatoin on eye and vision care research visit


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: